SCHEMBL2156707

SCHEMBL2156707

CC(C)(C)c1ccc(S(=O)(=O)O)c(CC2(Cc3cc(C(C)(C)C)ccc3S(=O)(=O)O)CSc3ccc(F)cc3C2=O)c1

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.31
NPY5R Q15761 1/20 0.31
ACHE P22303 1/20 0.30
PTGES2 Q9H7Z7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2157008 0.87 RYR2 (0.35)
SCHEMBL2156569 0.80 ALDH1A1 (0.33)
SCHEMBL2155601 0.79
SCHEMBL2155555 0.79 MEN1 (0.31)
SCHEMBL2157076 0.75 HSD11B1 (0.33)
SCHEMBL2748203 0.62 ALDH1A1 (0.41) ACHE
SCHEMBL14991466 0.61 PSEN1 (0.39)
SCHEMBL21300911 0.61 ALDH1A1 (0.50)
SCHEMBL14991258 0.61 PSEN1 (0.39)
SCHEMBL10382676 0.60 SMN1; SMN2 (0.44) NOTUMACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973072-B2 Pain, eating disorders, neurodegenerative disorders, memory impairment; attention deficit syndrome, opioid tolerance, drug addiction; (4-oxothiochroman-3,3-diyl)bis(methylene)bis(3-(trifluoromethyl)benzoate for example GRUENENTHAL GMBH (DE) 2011-07-05 US claimed
US-7973072-B2 Pain, eating disorders, neurodegenerative disorders, memory impairment; attention deficit syndrome, opioid tolerance, drug addiction; (4-oxothiochroman-3,3-diyl)bis(methylene)bis(3-(trifluoromethyl)benzoate for example GRUENENTHAL GMBH (DE) 2011-07-05 US disclosed